Anneleen Mortier

Anneleen Mortier

Auto-generated profile, based on publicly available information

Anneleen Mortier

Laboratory of Molecular Immunology, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Herestraat 49 box 1042, B-3000 Leuven, Belgium

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2013 in Immunology & Cell Biology
Verified
Journal Article
Closed access
PDF file
EMEva Av Moelants
Eva Av Moelants
AMAnneleen Mortier
Anneleen Mortier
JDJo Van Damme
Jo Van Damme
PPPaul Proost
Paul Proost

18 August 2008 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PPPaul Proost
Paul Proost
TLTamara Loos
Tamara Loos
AMAnneleen Mortier
Anneleen Mortier
ESEvemie Schutyser
Evemie Schutyser
MGMieke Gouwy
Mieke Gouwy
JDJo Van Damme
Jo Van Damme
Biological functions of proteins are influenced by posttranslational modifications such as on/off switching by phosphorylation and modulation by glycosylation. Proteolytic processing regulates cytokine and chemokine activities. In this study, we report that natural posttranslational citrullination or deimination alters the biological activities of the neutrophil chemoattractant and angiogenic cytokine CXCL8/interleukin-8 (IL-8). Citrullination of arginine in position 5 was discovered on 14% of natural leukocyte-derived CXCL8(1–77), generating CXCL8(1–77)Cit5. Peptidylarginine deiminase (PAD) is known to citrullinate structural proteins, and it may initiate autoimmune diseases. PAD efficiently and site-specifically citrullinated CXCL5, CXCL8, CCL17, CCL26, but not IL-1β. In comparison with CXCL8(1–77), CXCL8(1–77)Cit5 had reduced affinity for glycosaminoglycans and induced less CXCR2-dependent calcium signaling and extracellular signal-regulated kinase 1/2 phosphorylation. In contrast to CXCL8(1–77), CXCL8(1–77)Cit5 was resistant to thrombin- or plasmin-dependent potentiation into CXCL8(6–77). Upon intraperitoneal injection, CXCL8(6–77) was a more potent inducer of neutrophil extravasation compared with CXCL8(1–77). Despite its retained chemotactic activity in vitro, CXCL8(1–77)Cit5 was unable to attract neutrophils to the peritoneum. Finally, in the rabbit cornea angiogenesis assay, the equally potent CXCL8(1–77) and CXCL8(1–77)Cit5 were less efficient angiogenic molecules than CXCL8(6–77). This study shows that PAD citrullinates the chemokine CXCL8, and thus may dampen neutrophil extravasation during acute or chronic inflammation.

5 February 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
EVEvelina Vågesjö
Evelina Vågesjö
EÖEmelie Öhnstedt
Emelie Öhnstedt
AMAnneleen Mortier
Anneleen Mortier
HLHava Lofton
Hava Lofton
FHFredrik Huss
Fredrik Huss
MPMia Phillipson
Mia Phillipson
Significance: Chronic wounds comprise a growing clinical problem that represents >3% of the health care budget in industrialized countries. Drug development is hampered by the proteolytic nature of the wounds, which greatly limits drug bioavailability. Here, we present a technology that circumvents this by on-site production and reduced chemokine degradation. Lactobacilli bacteria were transformed into CXCL12-producing vectors to bioengineer the wound microenvironment after topical application. Consequently, the immune cells driving the healing process were reinforced, which greatly accelerated wound closure in healthy mice, in mouse models of hyperglycemia and peripheral ischemia, and in a wound model using human skin disks. Initial safety studies demonstrated that neither bacteria nor the chemokine produced was detected in systemic circulation following application to open wounds.

1 October 2008 in Blood
Verified
Journal Article
Closed access
PDF file
TLTamara Loos
Tamara Loos
AMAnneleen Mortier
Anneleen Mortier
MGMieke Gouwy
Mieke Gouwy
IRIsabelle Ronsse
Isabelle Ronsse
WPWilly Put
Willy Put
PPPaul Proost
Paul Proost
Interactions between chemokines and enzymes are vital in immunoregulation. Structural protein citrullination by peptidylarginine deiminase (PAD) has been associated with autoimmunity. In this report, we identified a novel naturally occurring posttranslational modification of chemokines, that is, the deimination of arginine at position 5 into citrulline of CXC chemokine ligand 10 (CXCL10) by rabbit PAD and human PAD2. Citrullination reduced (≥ 10-fold) the chemoattracting and signaling capacity of CXCL10 for CXC chemokine receptor 3 (CXCR3) transfectants; however, it did not affect CXCR3 binding. On T lymphocytes, though, citrullinated CXCL10 remained active but was again weaker than authentic CXCL10. PAD was also able to convert CXCL11, causing an impairment of CXCR3 signaling and T-cell activation, though less pronounced than for CXCL10. Similarly, receptor binding properties of CXCL11 were not altered by citrullination. However, deimination decreased heparin binding properties of both CXCL10 and CXCL11. Overall, chemokines are the first immune modulators reported of being functionally modified by citrullination. These data provide new structure-function dimensions for chemokines in leukocyte mobilization, disclosing an anti-inflammatory role for PAD. Additionally because citrullination has severe consequences for chemokine biology, this invites to reassess the involvement and impact of PAD and citrullinated peptides in inflammation, autoimmunity, and hematologic disorders.

1 November 2008 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
AMA Mortier
A Mortier
JVJ Vandamme
J Vandamme
PPPaul Proost
Paul Proost

1 July 2007 in Blood
Verified
Journal Article
Closed access
PDF file
PPPaul Proost
Paul Proost
AMAnneleen Mortier
Anneleen Mortier
TLTamara Loos
Tamara Loos
JVJo Vandercappellen
Jo Vandercappellen
MGMieke Gouwy
Mieke Gouwy
JDJo Van Damme
Jo Van Damme
The CD4 coreceptor is crucial in the activation of major histocompatibility complex (MHC) class II restricted CD4 + T lymphocytes by binding the same MHC class as the T-cell receptor (TCR) and by potentiating TCR-dependent signaling. CD4 is also expressed by invariant natural killer T cells (iNKT), which recognize natural and synthetic lipid antigens, such as α-galactosyl ceramide (α-GalCer), in association with the MHC class I–like CD1d molecule. Human iNKT cells can be divided into 2 major subsets depending on CD4 expression: CD4 + iNKT preferentially produce T-helper (Th)0/Th2 cytokines, whereas CD4− iNKT cells produce Th1 cytokines after antigenic activation. Cytokines produced by iNKT may have immunomodulatory roles in various physiopathologic contexts, but their mode of regulation by iNKT cells remains ill-defined. Using blocking reagents neutralizing CD4 binding, experimental systems where MHC class II molecules are absent and recombinant α-GalCer/CD1d complexes, we show that CD4 potentiates human iNKT cell activation by engaging CD1d molecules. These results indicate that the CD4 coreceptors may contribute to the fine tuning of iNKT cells reactivity.